Technical Analysis for AMRN - Amarin Corporation plc

Grade Last Price % Change Price Change
D 5.72 -1.89% -0.11
AMRN closed down 1.89 percent on Thursday, March 4, 2021, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical AMRN trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Fell Below 200 DMA Bearish -1.89%
Lower Bollinger Band Walk Weakness -1.89%
Wide Bands Range Expansion -1.89%
Below Lower BB Weakness -1.89%
Down 3 Days in a Row Weakness -1.89%
Down 4 Days in a Row Weakness -1.89%
Down 5 Days in a Row Weakness -1.89%
Lower Bollinger Band Touch Weakness -1.89%
Oversold Stochastic Weakness -1.89%
Older End-of-Day Signals for AMRN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 6 hours ago
60 Minute Opening Range Breakdown about 7 hours ago
Down 3% about 9 hours ago
Down 2 % about 10 hours ago
Down 1% about 10 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Amarin Corporation plc Description

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Acid Organic Compounds Therapeutic Product Cardiovascular Disease Lipid Therapeutic Products Acids Nutrition Vascular Diseases Cardiovascular Diseases Cholesterol Icos Fatty Acid Lipoprotein Fatty Acids Lipids Triglyceride Low Density Lipoprotein Hypertriglyceridemia Polyunsaturated Fat Saturated Fat

Is AMRN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 14.7
52 Week Low 3.36
Average Volume 7,968,958
200-Day Moving Average 5.96
50-Day Moving Average 6.63
20-Day Moving Average 7.36
10-Day Moving Average 6.70
Average True Range 0.48
ADX 34.6
+DI 15.42
-DI 37.38
Chandelier Exit (Long, 3 ATRs ) 7.81
Chandelier Exit (Short, 3 ATRs ) 6.84
Upper Bollinger Band 9.06
Lower Bollinger Band 5.67
Percent B (%b) 0.02
BandWidth 46.02
MACD Line -0.26
MACD Signal Line 0.03
MACD Histogram -0.2944
Fundamentals Value
Market Cap 2.22 Billion
Num Shares 389 Million
EPS -0.27
Price-to-Earnings (P/E) Ratio -21.50
Price-to-Sales 3.11
Price-to-Book 3.17
PEG Ratio -1.74
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.53
Resistance 3 (R3) 6.52 6.23 6.40
Resistance 2 (R2) 6.23 6.03 6.24 6.35
Resistance 1 (R1) 5.98 5.90 5.84 5.99 6.30
Pivot Point 5.69 5.69 5.62 5.70 5.69
Support 1 (S1) 5.44 5.49 5.30 5.45 5.14
Support 2 (S2) 5.15 5.36 5.16 5.09
Support 3 (S3) 4.90 5.15 5.05
Support 4 (S4) 4.91